把三张表、经营指标、SEC / 巨潮 / 港交所原始财报、业绩材料和电话会放到同一条可核验时间线上。 披露事实、结构化补位值与派生指标分开标注，缺失逐字稿不会用摘要或模型生成内容补齐。
单季、累计、年度和资产负债表时点分开保存；每个数值都保留单位、申报日、表单、XBRL 概念或原始中文字段。
美股链接 SEC 法定申报和发行人 IR，A 股链接巨潮原始 PDF，港股链接港交所披露易原始年报与中报。分部、订单、产能和客户集中度只在有可核验披露时展示。
官方电话会入口与已授权逐字稿分开。没有合法取得的全文时只显示材料可用性，不生成或拼接虚假的逐字稿。
三张表会执行资产负债、毛利润、税前利润等勾稽检查；超出容差的记录保留原值并标记警告， 不会为了让公式“对上”而修改公司披露。
| 2026-06-30 |
| 3/3 |
| $418.76M |
| $4.48M |
| $5.45M |
| 52.5% |
| 4.6% |
| 99 |
| 尚无授权文本 |
| NBIX NEUROCRINE BIOSCIENCES INC | 2026-06-30 | 3/3 | $959M | $144.4M | $265.3M | — | 15.8% | 91 | 尚无授权文本 |
| WVE Wave Life Sciences Ltd. | 2026-06-30 | 3/3 | $2.27M | -$69.36M | -$114.46M | — | -3248.3% | 121 | 尚无授权文本 |
| TMO THERMO FISHER SCIENTIFIC INC. | 2026-06-27 | 3/3 | $11.99B | $1.74B | $2.49B | — | 17.4% | 99 | 尚无授权文本 |
| LEXX Lexaria Bioscience Corp. | 2026-05-31 | 3/3 | $0 | -$1.99M | -$4.82M | 100.0% | -25096.7% | 103 | 尚无授权文本 |
| CIEN CIENA CORP | 2026-05-02 | 3/3 | $1.57B | $218.22M | $372.41M | 44.0% | 15.1% | 75 | 尚无授权文本 |
| SAIC Science Applications International Corp | 2026-05-01 | 3/3 | $1.91B | $115M | $118M | 13.1% | 9.4% | 110 | 尚无授权文本 |
| ANIX Anixa Biosciences Inc | 2026-04-30 | 3/3 | — | -$2.52M | — | — | — | 50 | 尚无授权文本 |
| CNXU Conexeu Sciences Inc. | 2026-04-30 | 3/3 | — | -$2.3M | -$3.38M | — | — | 4 | 尚无授权文本 |
| HSCS HeartSciences Inc. | 2026-04-30 | 3/3 | $4,319 | -$9.14M | -$7.43M | 59.1% | -194787.4% | 102 | 尚无授权文本 |
| KEQU KEWAUNEE SCIENTIFIC CORP /DE/ | 2026-04-30 | 3/3 | $282M | $9.62M | — | 28.5% | 5.9% | 89 | 尚无授权文本 |
| USNA USANA HEALTH SCIENCES INC | 2026-04-04 | 3/3 | $250.22M | $7.52M | $7.11M | 76.2% | 5.5% | 69 | 尚无授权文本 |
| ACHV ACHIEVE LIFE SCIENCES, INC. | 2026-03-31 | 3/3 | — | -$10.17M | — | — | — | 86 | 尚无授权文本 |
| AIFF FIREFLY NEUROSCIENCE, INC. | 2026-03-31 | 3/3 | $485,000 | -$2M | — | 45.6% | -414.4% | 101 | 尚无授权文本 |
| ALMR Alamar Biosciences, Inc. | 2026-03-31 | 3/3 | $26.04M | -$21.33M | -$20.95M | 55.5% | -47.4% | 4 | 尚无授权文本 |
| ANRO Alto Neuroscience, Inc. | 2026-03-31 | 3/3 | — | -$26.24M | -$27.65M | — | — | 38 | 尚无授权文本 |
| ARTL ARTELO BIOSCIENCES, INC. | 2026-03-31 | 3/3 | — | -$2.96M | — | — | — | 84 | 尚无授权文本 |
| ASMB ASSEMBLY BIOSCIENCES, INC. | 2026-03-31 | 3/3 | — | -$9.08M | -$22.12M | — | — | 97 | 尚无授权文本 |
| AURA Aura Biosciences, Inc. | 2026-03-31 | 3/3 | — | -$33.69M | -$30M | — | — | 69 | 尚无授权文本 |
| BENF Beneficient | 2026-03-31 | 3/3 | -$39.13M | -$87.43M | -$38.81M | — | 425.6% | 93 | 尚无授权文本 |
| BSX BOSTON SCIENTIFIC CORP | 2026-03-31 | 3/3 | $5.2B | $1.34B | $171M | 69.5% | 21.2% | 111 | 尚无授权文本 |
| CAI Caris Life Sciences, Inc. | 2026-03-31 | 3/3 | $216.17M | -$510,000 | $22.53M | — | 2.4% | 13 | 尚无授权文本 |
| CLRB Cellectar Biosciences, Inc. | 2026-03-31 | 3/3 | — | -$5.65M | -$4.85M | — | — | 126 | 尚无授权文本 |
| COGT Cogent Biosciences, Inc. | 2026-03-31 | 3/3 | — | -$97.35M | -$87.33M | — | — | 83 | 尚无授权文本 |
| CRBU Caribou Biosciences, Inc. | 2026-03-31 | 3/3 | $2.4M | -$25.09M | -$27.06M | — | -1096.4% | 89 | 尚无授权文本 |
| CTKB Cytek Biosciences, Inc. | 2026-03-31 | 3/3 | $44.14M | -$18.87M | -$4.9M | 48.2% | -41.8% | 63 | 尚无授权文本 |
| DARE Dare Bioscience, Inc. | 2026-03-31 | 3/3 | $152,455 | -$3M | -$5.52M | -58.9% | -1967.1% | 139 | 尚无授权文本 |
| DTIL PRECISION BIOSCIENCES INC | 2026-03-31 | 3/3 | $10.84M | -$18.44M | — | — | -83.7% | 126 | 尚无授权文本 |
| ENSC Ensysce Biosciences, Inc. | 2026-03-31 | 3/3 | $960,999 | -$3.56M | — | — | -370.7% | 122 | 尚无授权文本 |
| ENVB Enveric Biosciences, Inc. | 2026-03-31 | 3/3 | — | -$1.63M | — | — | — | 172 | 尚无授权文本 |
| EW Edwards Lifesciences Corp | 2026-03-31 | 3/3 | $1.65B | $380.7M | -$21.1M | 78.0% | 29.0% | 71 | 尚无授权文本 |
| FBRX Forte Biosciences, Inc. | 2026-03-31 | 3/3 | — | -$22.14M | -$18.81M | — | — | 78 | 尚无授权文本 |
| GILD GILEAD SCIENCES, INC. | 2026-03-31 | 3/3 | $6.96B | $2.02B | $2.43B | 79.2% | 37.2% | 83 | 尚无授权文本 |
| GLSI Greenwich LifeSciences, Inc. | 2026-03-31 | 3/3 | — | -$5.66M | — | — | — | 54 | 尚无授权文本 |
| HBIO HARVARD BIOSCIENCE INC | 2026-03-31 | 3/3 | $20.76M | -$3.42M | -$1.09M | 59.0% | -5.7% | 89 | 尚无授权文本 |
| HRMY Harmony Biosciences Holdings, Inc. | 2026-03-31 | 3/3 | $215.39M | $32.49M | — | 79.3% | 17.3% | 94 | 尚无授权文本 |
| HURA TuHURA Biosciences, Inc./NV | 2026-03-31 | 3/3 | $0 | -$7.54M | -$4.46M | — | — | 142 | 尚无授权文本 |
| IDYA IDEAYA Biosciences, Inc. | 2026-03-31 | 3/3 | $6.56M | -$98.54M | -$76.14M | — | -1654.6% | 111 | 尚无授权文本 |
| INBX Inhibrx Biosciences, Inc. | 2026-03-31 | 3/3 | — | -$33.44M | -$38.03M | — | — | 32 | 尚无授权文本 |
| JBIO Jade Biosciences, Inc. | 2026-03-31 | 3/3 | — | -$40.37M | — | — | — | 77 | 尚无授权文本 |
| JUNS JUPITER NEUROSCIENCES, INC. | 2026-03-31 | 3/3 | $18,652 | -$2.06M | — | 76.6% | -10524.3% | 28 | 尚无授权文本 |
| KOD Kodiak Sciences Inc. | 2026-03-31 | 3/3 | — | -$58.16M | -$40.95M | — | — | 66 | 尚无授权文本 |
| MBX MBX Biosciences, Inc. | 2026-03-31 | 3/3 | — | -$23.52M | -$20.65M | — | — | 32 | 尚无授权文本 |
| MLSS MILESTONE SCIENTIFIC INC. | 2026-03-31 | 3/3 | — | -$839,853 | $85,210 | — | — | 67 | 尚无授权文本 |
| MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. | 2026-03-31 | 3/3 | $65.84M | -$3.73M | $4.23M | 51.2% | -3.3% | 76 | 尚无授权文本 |
| NAGE Niagen Bioscience, Inc. | 2026-03-31 | 3/3 | $31.47M | $6.32M | — | 63.5% | 5.0% | 91 | 尚无授权文本 |
| NDRA ENDRA Life Sciences Inc. | 2026-03-31 | 3/3 | — | -$1.31M | — | — | — | 104 | 尚无授权文本 |
| NERV Minerva Neurosciences, Inc. | 2026-03-31 | 3/3 | — | -$125.4M | — | — | — | 73 | 尚无授权文本 |
| OACC Oaktree Acquisition Corp. III Life Sciences | 2026-03-31 | 3/3 | — | $1.39M | — | — | — | 14 | 尚无授权文本 |
| OACCU Oaktree Acquisition Corp. III Life Sciences | 2026-03-31 | 3/3 | — | $1.39M | — | — | — | 14 | 尚无授权文本 |
| PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 2026-03-31 | 3/3 | $37.18M | -$8.28M | -$47.73M | 34.5% | -22.5% | 105 | 尚无授权文本 |
| PAL Proficient Auto Logistics, Inc | 2026-03-31 | 3/3 | — | -$6.49M | $1.2M | — | — | 29 | 尚无授权文本 |
| PCRX Pacira BioSciences, Inc. | 2026-03-31 | 3/3 | $177.38M | $2.92M | $22.96M | 79.5% | 3.9% | 112 | 尚无授权文本 |
| PLSE PULSE BIOSCIENCES, INC. | 2026-03-31 | 3/3 | $401,000 | -$18.58M | -$14.63M | 7.7% | -4775.6% | 140 | 尚无授权文本 |
| PMN ProMIS Neurosciences Inc. | 2026-03-31 | 3/3 | — | -$8.24M | — | — | — | 76 | 尚无授权文本 |
| RCUS Arcus Biosciences, Inc. | 2026-03-31 | 3/3 | $7M | -$128M | -$138M | — | -1914.3% | 89 | 尚无授权文本 |
| REVB REVELATION BIOSCIENCES, INC. | 2026-03-31 | 3/3 | — | -$3.01M | -$3.29M | — | — | 117 | 尚无授权文本 |
| RKDA Arcadia Biosciences, Inc. | 2026-03-31 | 3/3 | $1.1M | -$4.39M | — | 36.4% | -70.8% | 91 | 尚无授权文本 |
| ROIV Roivant Sciences Ltd. | 2026-03-31 | 3/3 | $8.26M | -$299.77M | -$758.56M | — | -6235.7% | 93 | 尚无授权文本 |
| SCNX Scienture Holdings, Inc. | 2026-03-31 | 3/3 | $56,325 | -$3.4M | — | 95.6% | -6230.8% | 132 | 尚无授权文本 |
| SGHT Sight Sciences, Inc. | 2026-03-31 | 3/3 | $19.7M | -$12.98M | -$7.09M | 86.2% | -63.0% | 84 | 尚无授权文本 |
| SGMT Sagimet Biosciences Inc. | 2026-03-31 | 3/3 | — | -$10.65M | — | — | — | 60 | 尚无授权文本 |
| SKYE Skye Bioscience, Inc. | 2026-03-31 | 3/3 | — | -$12.51M | -$8.56M | — | — | 82 | 尚无授权文本 |
| SLDB Solid Biosciences Inc. | 2026-03-31 | 3/3 | — | -$56.74M | -$47.4M | — | — | 69 | 尚无授权文本 |
| SLS SELLAS Life Sciences Group, Inc. | 2026-03-31 | 3/3 | — | -$8.41M | — | — | — | 106 | 尚无授权文本 |
| SNTI Senti Biosciences Holdings, Inc. | 2026-03-31 | 3/3 | $16,000 | -$4.22M | — | — | -28850.0% | 91 | 尚无授权文本 |
| SPRB SPRUCE BIOSCIENCES, INC. | 2026-03-31 | 3/3 | — | -$12.27M | -$8.74M | — | — | 85 | 尚无授权文本 |
| TLSI TriSalus Life Sciences, Inc. | 2026-03-31 | 3/3 | $8.9M | $1.54M | -$6.62M | 86.2% | -94.5% | 107 | 尚无授权文本 |
| TWST Twist Bioscience Corp | 2026-03-31 | 3/3 | — | -$44.02M | -$60.23M | — | — | 54 | 尚无授权文本 |
| TYRA Tyra Biosciences, Inc. | 2026-03-31 | 3/3 | — | -$39.31M | -$32.66M | — | — | 62 | 尚无授权文本 |
| XBIO Xenetic Biosciences, Inc. | 2026-03-31 | 3/3 | $806,923 | -$456,382 | — | — | -62.2% | 81 | 尚无授权文本 |
| AVXL ANAVEX LIFE SCIENCES CORP. | 2025-12-31 | 3/3 | — | -$5.68M | — | — | — | 58 | 尚无授权文本 |
| BHST BIOHARVEST SCIENCES INC. | 2025-12-31 | 3/3 | $34.51M | -$11.14M | -$9.58M | 59.3% | -16.2% | 85 | 尚无授权文本 |
| GNTA Genenta Science S.p.A. | 2025-12-31 | 3/3 | — | -$6.53M | -$6.88M | — | — | 52 | 尚无授权文本 |
| MSLE Satellos Bioscience Inc. | 2025-12-31 | 2/3 | — | -$24.87M | — | — | — | 20 | 尚无授权文本 |
| NBP NovaBridge Biosciences | 2025-12-31 | 3/3 | — | -$46.27M | — | — | — | 148 | 尚无授权文本 |
| SJ Scienjoy Holding Corp | 2025-12-31 | 3/3 | — | -$587.09M | $9.96M | — | — | 83 | 尚无授权文本 |
| RGC Regencell Bioscience Holdings Ltd | 2025-06-30 | 3/3 | — | -$3.58M | -$3.27M | — | — | 39 | 尚无授权文本 |
| MLEC Moolec Science SA | 2024-12-31 | 2/3 | — | -$2.43M | — | — | — | 66 | 尚无授权文本 |
| TLSA Tiziana Life Sciences Ltd | 2024-12-31 | 2/3 | — | -$11.86M | — | — | — | 276 | 尚无授权文本 |
| BME BlackRock Health Sciences Trust | — | 0/3 | — | — | — | — | — | 1 | 尚无授权文本 |
| BMEZ BlackRock Health Sciences Term Trust | — | 0/3 | — | — | — | — | — | 0 | 尚无授权文本 |
| BST BlackRock Science & Technology Trust | — | 0/3 | — | — | — | — | — | 1 | 尚无授权文本 |
| BSTZ BlackRock Science & Technology Term Trust | — | 0/3 | — | — | — | — | — | 1 | 尚无授权文本 |
| HQL abrdn Life Sciences Investors | — | 0/3 | — | — | — | — | — | 1 | 尚无授权文本 |
| SLBT SL Science Holding Ltd | — | 0/3 | — | — | — | — | — | 3 | 尚无授权文本 |